Related Experiment Video
Updated: May 31, 2026

10:58
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
Exploring synchronous endometrial and ovarian cancers.
Samreen Zaheer1, Aditi Agrawal2, Samaresh Swain1
1Jawaharlal Nehru Medical College, Department of Radiotherapy and Clinical Oncology, Aligarh Muslim University Faculty of Medicine, Aligarh, Uttar Pradesh, India.
BMJ Case Reports
|May 29, 2026
Summary
Distinguishing synchronous female genital tract tumors from metastatic cancers is crucial for appropriate treatment and better prognosis. This study highlights three cases of synchronous primary endometrial and ovarian carcinomas.
Area of Science:
- Gynecologic Oncology
- Pathology
- Surgical Oncology
Background:
- Synchronous tumors in the female genital tract require differentiation from metastatic disease.
- Accurate diagnosis impacts treatment strategies and patient prognosis.
- Lower abdominal pain is a common presenting symptom.
Purpose of the Study:
- To differentiate synchronous primary endometrial and ovarian carcinomas from metastatic cancers.
- To emphasize the importance of distinct treatment approaches and improved prognosis for synchronous tumors.
- To report on three cases of synchronous primary endometrial and ovarian carcinoma.
Main Methods:
- Case series presentation.
- Review of patient histories and diagnostic findings.
- Surgical pathology confirmation following total abdominal hysterectomy with bilateral salpingo-oophorectomy.
Main Results:
- Three patients presented with lower abdominal pain.
- All three patients were diagnosed with synchronous primary endometrial and ovarian carcinoma post-surgery.
- Surgical intervention included total abdominal hysterectomy with bilateral salpingo-oophorectomy.
Conclusions:
- Synchronous primary endometrial and ovarian carcinomas can present similarly to metastatic disease.
- Timely diagnosis and appropriate management are essential for favorable outcomes.
- Surgical pathology is key in confirming synchronous primary malignancies of the female reproductive system.
